Brent Fraser
Ottawa, ON K1S5S8, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 5 publications
The CADTH pCODR Expert Review Committee Process Explained. Comment on Rayson et al. Access to Neoadjuvant Pertuzumab for HER2 Positive Breast Cancer in Canada: A Dilemma Increasingly Difficult to Explain. Curr. Oncol. 2022, 29, 9891-9895.
Journal: Current oncology (Toronto, Ont.)
Published: February 28, 2023
Access to novel drugs and therapeutics for children and youth: Eliciting citizens' values to inform public funding decisions.
Journal: Health expectations : an international journal of public participation in health care and health policy
Published: August 10, 2022
Building a National Reassessment Process for Oncology Drugs: Lessons Learned by the Canadian Real-World Evidence for Value of Cancer Drugs (CanREValue) Collaboration through a Simulated Reassessment Exercise.
Journal: Current oncology (Toronto, Ont.)
Published: October 09, 2021
Considerations for Developing a Reassessment Process: Report from the Canadian Real-World Evidence for Value of Cancer Drugs (CanREValue) Collaboration's Reassessment and Uptake Working Group.
Journal: Current oncology (Toronto, Ont.)
Published: August 28, 2021
Drug costs in Canada.
Journal: Canadian pharmacists journal : CPJ = Revue des pharmaciens du Canada : RPC
Published: November 23, 2017
Showing 1-5 of 5
Last Updated: 09/26/2026